Article
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population.
Scientific reports - 21 May 2024
Grauen Larsen Helena, Sun Jiangming, Sjögren Marketa, Borné Yan, Engström Gunnar, Nilsson Peter, Orho-Melander Marju, Goncalves Isabel, Nilsson Jan, Melander Olle, Schiopu Alexandru
Abstract excerpt
The receptor for advanced glycation endproducts (RAGE) has pro-inflammatory and pro-atherogenic effects. Low plasma levels of soluble RAGE (sRAGE), a decoy receptor for RAGE ligands, have been associated with increased risk for major adverse coronary events (MACE) in the general population. We performed a genome-wide association study to identify genetic determinants of plasma sRAGE in 4338 individuals from the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
